Unirisco is a venture capital company that, on the initiative of Galician Universities, was set up in November 2000 with the aim of promoting the creation of high tech companies, through short - medium term investment operations in their equity, always with the criteria of profitability and job creation in mind.
Current portfolio: Centauri, Galchimia, Nanogap, Pharmatools, Situm and Appentra.
Divestments: Immunostep, Advancell, Amslab, Balneario Rio Pambre, BioGea, Bit Oceans, Devalar, Enxenio, Galicia Banner, Genomix, Gimena, Health in Code, Helionova, Hifas da Terra, Innolact, Keramat, Neoker, Proxectos, Signo and Xenotechs.
• Industrial technologies
• New Materials
• Biotechnology and Health Technologies
Yolanda Falcón García (Chief Investment Officer)
Maria José Conde (Director`s assistant)
Edificio Emprendia - Campus Vida
15782 Santiago de Compostela - Spain
(+34) 881 815 550
email@example.com / firstname.lastname@example.org